Transcriptomic overview of EML4-ALK lung cancer cells resistant to ALK inhibitors highlights a vulnerability to CDK inhibitors
Authors
Paliouras, Athanasios RMagee, Peter
Sahoo, Sudhakar
Leong, Hui Sun
Krebs, Matthew G
Blackhall, Fiona H
Lovly, CM
Garofalo, Michela
Affiliation
CRUK MI, University of Manchester, Manchester,Issue Date
2019
Metadata
Show full item recordCitation
Paliouras AR, Magee P, Sahoo S, Leong HS, Krebs MG, Blackhall FH, et al. Transcriptomic overview of EML4-ALK lung cancer cells resistant to ALK inhibitors highlights a vulnerability to CDK inhibitors. Cancer Res. 2019;79(13).Journal
Cancer ResearchDOI
10.1158/1538-7445.AM2019-4761Additional Links
https://dx.doi.org/10.1158/1538-7445.AM2019-4761Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1158/1538-7445.AM2019-4761